GENEBRU
ActiveSummary
GENEBRU has been active since 1983 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €70,231. Equity is growing by ~3.8% per year across the filed fiscal years. Its solvency ranks better than 53% of 5662 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Back to profitnet €70,231
Net result €70,231 after one loss-making year.
31-12
Financial
Liquidity times 20current ratio 2.59
Current ratio from 0.13 to 2.59.
10-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
23-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 23 days late
2023
31-12
Financial
Equity above €1mEq €1.1m ▲5.8%
5 profitable years in a row build equity to €1.1m.
17-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
07-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Liquidity doublescurrent ratio 34.16
Current ratio from 14.58 to 34.16; short-term debt falls from €60,067 to €26,455.
12-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 12 days late
2020
03-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 3 days late
2019
31-12
Financial
Back to profitnet €69,301
Net result €69,301 after one loss-making year.
Show earlier events
12-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 12 days late
2018
24-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 24 days late
2017
22-09
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 53 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.